** Shares of Adherium ADR.AX rise as much as 63.2% to
A$0.031, their biggest intraday gain since April 15
** Stock hits its highest level since April 19
** Medication monitoring software co says pharmaceutical
giant AstraZeneca AZN.L chose ADR's Hailie Smartinhaler
platform for its clinical trial
** Says contract for A$1.1 mln ($726,110.00) over three
years
** Over 13.3 mln shares change hands, compared with the
30-day average volume of around 4.5 mln
** Stock down 64.5% YTD as of last close
($1 = 1.5149 Australian dollars)
(Reporting by Aaditya Govind Rao in Bengaluru)
((Aaditya.govindrao@thomsonreuters.com;))